Molecular therapy in the microRNA era
T Wurdinger, FF Costa - The pharmacogenomics journal, 2007 - nature.com
MicroRNAs (miRNAs) consist of a growing class of non-coding RNAs (ncRNAs) that
negatively regulate the expression of genes involved in development, differentiation …
negatively regulate the expression of genes involved in development, differentiation …
MicroRNA therapeutics in neurological disease
DS Greenberg, H Soreq - Current pharmaceutical design, 2014 - ingentaconnect.com
Developing microRNA therapeutics for neurological diseases is both a promising
opportunity and an extremely challenging topic for several reasons. The promise stems from …
opportunity and an extremely challenging topic for several reasons. The promise stems from …
[HTML][HTML] Stroke-induced microRNAs: The potential therapeutic role for stroke
P Wu, X Zuo, A Ji - Experimental and therapeutic …, 2012 - spandidos-publications.com
Stroke is one of the leading causes of death and disability worldwide. In past decades,
researchers have studied the physiopathology and biochemistry of stroke, but knowledge of …
researchers have studied the physiopathology and biochemistry of stroke, but knowledge of …
miRNAs as therapeutic targets in inflammatory disease
Q Lu, R Wu, M Zhao, A Garcia-Gomez… - Trends in pharmacological …, 2019 - cell.com
In the past decade, we have witnessed considerable developments in understanding the
roles and functions of miRNAs. In parallel, the identification of alterations in miRNA …
roles and functions of miRNAs. In parallel, the identification of alterations in miRNA …
MicroRNAs: newcomers into the ALS picture
C Volonté, S Apolloni, C Parisi - CNS & Neurological Disorders …, 2015 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) causes neurodegeneration of both upper and lower
motor neurons and progressive muscle impairment, atrophy and death within approximately …
motor neurons and progressive muscle impairment, atrophy and death within approximately …
Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease
Remarkable advances in understanding the role of RNA in health and disease have
expanded considerably in the last decade. RNA is becoming an increasingly important …
expanded considerably in the last decade. RNA is becoming an increasingly important …
Midbrain dopamine neurons in Parkinson׳ s disease exhibit a dysregulated miRNA and target-gene network
The degeneration of substantia nigra (SN) dopamine (DA) neurons in sporadic Parkinson׳ s
disease (PD) is characterized by disturbed gene expression networks. Micro (mi) RNAs are …
disease (PD) is characterized by disturbed gene expression networks. Micro (mi) RNAs are …
[HTML][HTML] miR-182-5p and miR-183-5p act as GDNF mimics in dopaminergic midbrain neurons
AE Roser, LC Gomes, R Halder, G Jain, F Maass… - … Therapy-Nucleic Acids, 2018 - cell.com
Parkinson's disease (PD) is the second-most-frequent neurodegenerative disorder
worldwide. One major hallmark of PD is the degeneration of dopaminergic (DA) neurons in …
worldwide. One major hallmark of PD is the degeneration of dopaminergic (DA) neurons in …
[HTML][HTML] The path to microRNA therapeutics in psychiatric and neurodegenerative disorders
The microRNA (miRNA) class of non-coding RNAs exhibit a diverse range of regulatory
roles in neuronal functions that are conserved from lower vertebrates to primates. Disruption …
roles in neuronal functions that are conserved from lower vertebrates to primates. Disruption …
[HTML][HTML] miRNAs: The road from bench to bedside
G Iacomino - Genes, 2023 - mdpi.com
miRNAs are small noncoding RNAs that control gene expression at the posttranscriptional
level. It has been recognised that miRNA dysregulation reflects the state and function of cells …
level. It has been recognised that miRNA dysregulation reflects the state and function of cells …